<DOC>
	<DOCNO>NCT00432731</DOCNO>
	<brief_summary>Primary objective : To describe safety profile refrigerator-stable formulation VARIVAX® first single dose injection 12 15 month-old infant 42-day follow-up period post-vaccination . Secondary objective : NA</brief_summary>
	<brief_title>Safety Study Refrigerator-stable Formulation VARIVAX®</brief_title>
	<detailed_description />
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<criteria>1 . Healthy infant 12 month age 15 month age . 2 . Consent form sign parent legal representative ( ) , properly inform study , 3 . Parent ( ) able understand protocol requirement fill Diary Card . 1 . Prior receipt measles , mumps , rubella varicella vaccine either alone combination vaccine , 2 . Known suspected clinical history infection measles , mumps , rubella , varicella zoster , 3 . Any known recent ( ≤30 day ) exposure measles , mumps rubella , 4 . Any known recent ( ≤30 day ) exposure varicella zoster involve : 5 . Any recent ( ≤3 day ) history febrile illness ( rectal temperature ≥38.0°C ) , 6 . Active untreated tuberculosis , 7 . Any known blood dyscrasia , leukemia , lymphomas type , malignant neoplasm affect bone marrow lymphatic system , 8 . Any immune impairment humoral/cellular deficiency , neoplastic disease depress immunity , 9 . Any previous ( ≤150 day ) receipt immune serum globulin bloodderived product schedule administer visit 3 , 10 . Any recent receipt inactivate live vaccine ( ≤ 30 day ) schedule vaccination visit 3</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention : Varicella</keyword>
	<keyword>Measles</keyword>
	<keyword>Mumps</keyword>
	<keyword>Rubella</keyword>
</DOC>